ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
Dow Jones
40,003.59
0.34%
Brent Oil
83.595
0.00%
Bitcoin
66,169.21
-0.16%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Eupraxia Pharmaceuticals Inc (EPRX) Quote

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
2.94
-0.01
(-0.34%)
Closed May 19 4:00PM
Delayed by 15 minutes
2.94
0.00
(0.00%)
After Hours: 4:02PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.94
Bid
2.86
Ask
2.99
Volume
4,760
2.90 Day's Range 2.95
2.48 52 Week Range 3.55
Market Cap
108.855M
Previous Close
2.95
Open
2.90
Last Trade
304
@
2.94
Last Trade Time
Financial Volume
$ 13,947
VWAP
2.93
Average Volume (3m)
23,727
Shares Outstanding
27,282,000
Dividend Yield
-
PE Ratio
-3.86
Earnings Per Share (EPS)
-1.03
Revenue
-
Net Profit
-28.22M

About Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eupraxiapharma.com
Headquarters
Victoria, British Columbia, Can
Founded
1970
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $2.95. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 2.48 to $ 3.55.

Eupraxia Pharmaceuticals currently has 27,282,000 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $108.86 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.86.

EPRX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 15 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 14 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024

Eupraxia Pharmaceuticals to Present Initial Results from Ongoing Phase 1b Study of EP-104GI for the Treatment of Eosinophilic Esophagitis at Upcoming Digestive Disease Week Annual Meeting 2024 PR...

May 14 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 08 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire VICTORIA, BC, May 8, 2024 Eupraxia common shares now listed on the Nasdaq Capital...

May 08 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board

Eupraxia Pharmaceuticals Announces Gastrointestinal Clinical Advisory Board PR Newswire VICTORIA, BC, May 2, 2024 --Advisory Board to Provide Guidance for Company's Eosinophilic Esophagitis...

May 02 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024

Eupraxia Pharmaceuticals Announces Upcoming Presentations at the Osteoarthritis Research Society International World Congress 2024 PR Newswire VICTORIA, BC, April 11, 2024 VICTORIA, BC, April 11...

April 11 2024
PR Newswire (US)

Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference

Eupraxia Pharmaceuticals To Present at Bloom Burton & Co. Healthcare Investor Conference PR Newswire VICTORIA, BC, April 8, 2024 VICTORIA, BC, April 8, 2024 /PRNewswire/ - Eupraxia...

April 08 2024
PR Newswire (US)

Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today

Eupraxia Pharmaceuticals Begins Trading on Nasdaq Today Canada NewsWire VICTORIA, BC, April 5, 2024 VICTORIA, BC, April 5, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the...

April 05 2024
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.041.379310344832.932.88121422.9211754CS
40.4417.62.53.082.5162492.8856938CS
12-0.61-17.18309859153.553.552.48237272.8577328CS
26-0.61-17.18309859153.553.552.48237272.8577328CS
52-0.61-17.18309859153.553.552.48237272.8577328CS
156-0.61-17.18309859153.553.552.48237272.8577328CS
260-0.61-17.18309859153.553.552.48237272.8577328CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DUOFangDD Network Group Ltd
$ 1.65
(313.74%)
104.68M
FLJFLJ Group Limited
$ 1.54
(220.90%)
57.28M
JFBRJeffs Brands Ltd
$ 0.6276
(102.45%)
37.97M
IPWiPower Inc
$ 2.89
(97.95%)
11.05M
CETXCemtrex Inc
$ 0.4851
(48.58%)
21.23M
BSFCBlue Star Foods Corporation
$ 0.0757
(-45.26%)
60.09M
SINTSiNtx Technologies Inc
$ 0.084602
(-39.57%)
156.35M
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
HSCSHeart Test Laboratories Inc
$ 7.00
(-38.11%)
348.9k
AMPGAmplitech Group Inc
$ 1.46
(-32.09%)
613.31k
CRKNCrown Electrokinetics Corporation
$ 0.171
(-28.75%)
1.74B
FFIEFaraday Future Intelligent Electric Inc
$ 1.0189
(-38.25%)
1.31B
GWAVGreenwave Technology Solutions Inc
$ 0.1541
(4.05%)
1.16B
AKANAkanda Corporation
$ 0.1726
(30.26%)
566.49M
PEGYPineapple Energy Inc
$ 0.1053
(-28.85%)
219.25M

Discussion

View Full Feed
th6565 th6565 5 minutes ago
Not half million, it was about $380k I put in.
NB
waterchaser waterchaser 5 minutes ago
Shameful how Trump views women… including his daughter.
DJT
janetcanada janetcanada 5 minutes ago
BLEG - "Dave also emphasized that one of his goals is to build equity for his children's future"

***I am Sure that he is not Investing money in his Own Company for you to Benefit!....

👀***Insider Trading Screener-" Add symbol"......
SecForm4.Com
h
BLEG
lasombra lasombra 6 minutes ago
RONN...
MrMike241 MrMike241 7 minutes ago
The shrimp and the crostini both look amazing!

I'd try the sauce, I bet it's flavorful, but I'm not excited about it. I could swap the sauce for that Mexican corn 😋
glenn1919 glenn1919 8 minutes ago
OPEN......................https://stockcharts.com/h-sc/ui?s=OPEN&p=W&b=5&g=0&id=p86431144783
OPEN
Samello Samello 9 minutes ago
I just made 3 Lbs of pepperoni, because I can no longer find pepperoni sticks at any of the stores in the area, they all have pre cut packs or it’s in the Deli case in 3 or4 inch round sticks that they cut for you like all other sausages, but I want different thicknesses for pizza or crackers or any
keepemcloser keepemcloser 9 minutes ago
DB it’s hard to understand how these supposed shareholders don’t count the fact that the stock that people buy in PP ‘s
Is held to maturity 6 months and the original proceeds of such sales go into VPLM’ bank account and out again for Lawyers etc to keep up the good fight.

In o
VPLM
AlwaysRed AlwaysRed 9 minutes ago
You know what know, you tell me..........

https://www.bullionvault.com/silver-price-chart.do

https://www.cmegroup.com/markets/metals/precious/silver.volume.html
SLV
Eli's Gone Eli's Gone 9 minutes ago
PGA Fantasy contest final standings:

Total birdies 1737,,,eagles 38

https://investorshub.advfn.com/uimage/uploads/2024/5/19/gkiisPGA_fantasy_round_4.png
https://investorshub.advfn.com/uimage/uploads/2024/5/19/pjlzjPGA_fantasy_round_4-2.png
JusDePomme JusDePomme 10 minutes ago
So basically CEO treats shareholders like his children? Nice
BLEG
glenn1919 glenn1919 11 minutes ago
VAXX................................https://stockcharts.com/h-sc/ui?s=VAXX&p=W&b=5&g=0&id=p86431144783
VAXX
HD2001 HD2001 11 minutes ago
I look at it this way it's an expensive lesson but I've met several new investors I trust . No less than QB listening from now on for me . But if take me five years I'll get even with Nash for all the lies .
XALL
UpTickMeA$AP UpTickMeA$AP 11 minutes ago
The FDIC has posted information, and of course, they're in charge, and have ALL the information.

The FDIC states:

The Receiver does not currently have and does not anticipate accumulating sufficient assets to pay in full all of the allowed claims of the general unsecur
COOP
janice shell janice shell 12 minutes ago
Gross!!!
a surfer a surfer 15 minutes ago
HMMM... LMAO. https://www.yahoo.com/news/arizona-poll-finds-trouble-biden-155318660.html?fr=sycsrp_catchall
DJT
arizona1 arizona1 15 minutes ago
It's pretty revolting, right? But apparently, they're a real thing.

https://c8.alamy.com/comp/2DDMTKR/former-mayor-rudolph-giuliani-republican-of-new-york-new-york-and-dr-maria-ryan-arrive-for-the-state-dinner-hosted-by-united-states-president-donald-j-trump-and-first-lady-melania-t
Fannie Heyyyyy Fannie Heyyyyy 15 minutes ago
Let's get this "free to discuss" the US Gov't theft of F&F. I'm honored to be the first poster.
janice shell janice shell 16 minutes ago
No reviews yet, but I think this would be good. I'm conflicted about the sun-dried tomatoes. I think the sauce would be fine without them, if necessary or desired. And probably the amount of sauce should be doubled. I like sauce.

Grilled Shrimp Cocktail with Fresh Tomato Cocktail Sau
newmedman newmedman 17 minutes ago
Yes, there are both sides to every debate. OMFG.

https://x.com/TheGoodLiars/status/1792300933474398449

full episode at....

https://podcasts.apple.com/us/podcast/the-good-liars-tell-the-truth/id1731178442?i=1000655713147
STRIKEEAGLE STRIKEEAGLE 17 minutes ago
Roger that PICK... now it's "really soon"...



STRIKE
COOP
janetcanada janetcanada 17 minutes ago
👀***BLEG- Link to the trades:.....
***https://ih.advfn.com/stock-market/USOTC/demand-brands-pk-BLEG/trades

👀***From Barchart.....
https://www.barchart.com/stocks/quotes/BLEG/overview

👀&#x
BLEG
delerious1 delerious1 18 minutes ago
Like I said there is always money dying to get in to a good runner...that is not a problem....the real issue is that we get the news that we expect
IGPK
janetcanada janetcanada 20 minutes ago
👀BLEG - ***HOW TO BUY PENNY STOCK***

The OTC Stocks Being Less Regulated they are subject to Scare Tactics and Manipulation!.......

***Once you've learned to dodge the scammers, there are five steps to follow when pur
BLEG

Your Recent History

NASDAQ
EPRX
Eupraxia Pharmaceuticals
NASDAQ
BUJAU
Bukit Jalil Global Acqui...
LSE
0Y9D
Db X-trackers Usd Corpor...
AMEX
GGO.C
LSE
REL
Relx
TSX
ARE
Aecon
LSE
GENF
Genflow Biosciences
AMEX
ATEST
NASDAQ
BREA
Brera
FX
NZBNZOCR
Reserve Bank of NZ Offic...
LSE
BOXE
Tritax Eurobox
NASDAQ
BHRB
Burke and Herbert Financ...
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved